← Back

Yifeng Pharmacy

Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. The company offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. It is also involved in chronic disease management, medical project investment, and medical technology development, as well as operates internet hospitals and clinics. The company also offers its products through franchise distribution and e-commerce. Yifeng Pharmacy Chain Co., Ltd. was founded in 2001 and is headquartered in Changsha, China.

Price · split & dividend adjusted
News & notes moving 603939.CG
603939.CG

Yifeng Pharmacy Chain Has Repurchased 1.78 Million Shares for 39.62 Million Yuan

Yifeng Pharmacy Chain announced that as of the disclosure date, it has repurchased 1.78 million shares, accounting for 0.15% of total share capital, with a total repurchase amount of 39.62 million yuan, at a price range of 22.01 yuan to 22.62 yuan per share. In the first quarter of 2026, the company achieved revenue of 6.085 billion yuan and net profit attributable to the parent company of 500 million yuan.
财中社·21dRead more ▾
603939.CG

Shanghai-listed companies announce over 15 billion yuan in new buyback and shareholding increase plans in one week

Over the past week, Shanghai-listed companies launched 42 new buyback plans with a maximum value of 8.386 billion yuan, and 17 new shareholding increase plans with a maximum value of 7.457 billion yuan, marking a clear acceleration in industrial capital entering the market. The chairman of NARI Technology proposed a buyback of 500 million to 1 billion yuan worth of shares, the chairman of Daqin Railway proposed a buyback of 400 million to 500 million yuan, Sany Heavy Industry plans to repurchase A-shares worth 400 million to 800 million yuan, and Yifeng Pharmacy Chain plans to repurchase shares worth 200 million to 300 million yuan. On the shareholding increase side, the controlling shareholder of China Three Gorges Renewables plans to increase holdings by 1.5 billion to 3 billion yuan, the controlling shareholder of Aluminum Corporation of China plans to increase holdings by 1 billion to 2 billion yuan, and the controlling shareholder of China State Construction Engineering plans to increase holdings by 500 million to 1 billion yuan. Since the beginning of this year, Shanghai-listed companies have disclosed 190 new buyback plans with a total maximum value of 55.5 billion yuan, and 155 new shareholding increase plans with a total maximum value of 22.1 billion yuan.
为自有及自筹资金·32dRead more ▾
603939.CG

Shanghai-Listed Companies Step Up Buybacks and Shareholder Increases This Year as Industrial Capital Continues to Flow In

A wave of share buybacks and shareholder increases continues to surge among companies listed on the Shanghai Stock Exchange, with the pace of industrial capital entering the market notably accelerating. Over the past week, 42 new buyback plans were added on the Shanghai market, with a maximum amount of 8.386 billion yuan, and 17 new shareholder increase plans were added, with a maximum amount of 7.457 billion yuan. Since the start of 2026, the Shanghai market has disclosed 190 new buyback plans, with a combined maximum amount reaching 55.5 billion yuan, and 155 new shareholder increase plans, with a maximum amount of 22.1 billion yuan. Many companies are making big moves. The chairman of NARI Technology proposed a buyback of 500 million to 1 billion yuan, the chairman of Daqin Railway proposed a buyback of 400 million to 500 million yuan, Sany Heavy Industry plans to buy back 400 million to 800 million yuan, and Yifeng Pharmacy Chain plans to buy back 200 million to 300 million yuan. The implementation of funds is also speeding up. Haier Smart Home has cumulatively bought back 1.817 billion yuan in this round, Seres has cumulatively bought back over 587 million yuan, Metallurgical Corporation of China has completed transactions totaling about 415 million yuan, and Chenguang Stationery has paid a total of 288 million yuan. On the shareholder increase side, the controlling shareholder of China Three Gorges Renewables plans to increase holdings by 1.5 billion to 3 billion yuan, the controlling shareholder of Aluminum Corporation of China plans to increase holdings by 1 billion to 2 billion yuan, and the controlling shareholder of China State Construction Engineering plans to increase holdings by 500 million to 1 billion yuan.
为自有资金或自筹资金·32dRead more ▾
603939.CG

Yifeng Pharmacy Plans to Buy Back Shares Worth 200 Million to 300 Million Yuan

Yifeng Pharmacy announced plans to repurchase shares through centralized bidding, with the buyback amount set at no less than 200 million yuan and no more than 300 million yuan. The maximum repurchase price is 30.56 yuan per share, and the buyback period will not exceed six months from the date of board approval. In the first quarter of 2026, the company reported revenue of 6.085 billion yuan and net profit attributable to the parent company of 500 million yuan.
财中社·34dRead more ▾
603939.CG

Yifeng Pharmacy Plans to Repurchase 200 Million to 300 Million Yuan of Company Shares

Yifeng Pharmacy disclosed an announcement, planning to use its own funds to repurchase company shares through centralized competitive trading, for use in employee stock ownership plans or equity incentives. The amount for this share repurchase is 200 million to 300 million yuan, with a repurchase price not exceeding 30.56 yuan per share. The estimated number of shares to be repurchased is approximately 6.54 million to 9.82 million shares, accounting for about 0.54% to 0.81% of the company's total share capital. The repurchase period shall not exceed six months from the date the company's board of directors approves the share repurchase plan.
北京商报·34dRead more ▾
603939.CG

Yifeng Pharmacy Appoints Hu Jianxia as Vice President

Yifeng Pharmacy has appointed Hu Jianxia as Vice President. The company convened the Nomination Committee of the Board of Directors and the 31st meeting of the fifth Board of Directors on July 20, approving the appointment of Hu Jianxia as Vice President. She will concurrently cease to serve as Assistant President. Her term of office begins from the date of approval by this Board meeting and ends upon the expiry of the fifth Board of Directors' term. In the first quarter of 2026, Yifeng Pharmacy achieved revenue of 6.085 billion yuan and net profit attributable to the parent company of 500 million yuan.
财中社·38dRead more ▾